Home Compare EW vs IPN.PA
Stock Comparison · Single-driver result

Edwards Lifesciences vs Ipsen: Which Stock Looks Stronger in 2026?

The structural profiles are close, with Edwards Lifesciences carrying a narrow edge on profitability. The remaining gap is narrow enough that the comparison remains open to different readings. The market setup is mixed, without a decisive signal in either direction. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

Profitability still does most of the heavy lifting in this comparison.

Trajectory Similarity
0.72
Similar
Peer-set rank: #2
within Edwards Lifesciences Corporation's functional peer set

This comparison is anchored in long-term financial trajectory similarity within the selected peer universe.

A solid similarity means the pair shares a clearly comparable long-term financial profile, even if individual dimensions still differ.

Most of the shared profile comes through revenue stability and capital structure.

Similarity drivers
revenue stabilitycapital structure
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
EW
Edwards Lifesciences Corporation
54
Peer-Score
Signal qualityHigh
vs
IPN.PA
Ipsen S.A.
50
Peer-Score
Signal qualityMedium

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

The clearest separation appears in profitability.

Dimension spread: EW vs IPN.PA Profitability 78 51 Stability 49 57 Valuation 41 43 Growth 44 51 EW IPN.PA
Gap Ranking
#1 Profitability +27
#2 Stability +8
#3 Growth +7
#4 Valuation +2
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for EW and IPN.PA Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer EWIPN.PA Relative valuation Structural strength

The setup is mixed: neither company clearly combines the stronger profile with the more supportive price setup.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Profitability
Both look solid on profitability, though Edwards Lifesciences Corporation still holds the stronger peer position.
Stability
On stability, the edge still sits with Ipsen S.A., even though both profiles look solid.
Profitability — Dominant Gap
EW
78
IPN.PA
51
Gap+27in favour of EW

The clearest distance comes from a stronger profitability profile.

What keeps the gap from being one-sided

Ipsen S.A. still looks less cycle-sensitive — that keeps the result from looking completely one-sided.

What this means for the comparison

The main read on profitability is clearer than the broader score gap.

Explore full peer positioning in AssetNext

Break down the EW vs IPN.PA comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar profitability-driven comparisons

Explore how EW and IPN.PA each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.